A Study of SPY003-207 in Healthy Volunteers
NCT06873724
Original registry description
This is a Phase 1, randomized, double-blind, placebo-controlled, single dose, first in human safety, tolerability, and pharmacokinetic study of SPY003-207 in healthy participants.